The company started in 1958 and was listed on the Shanghai Stock Exchange in 1993. It is the first listed company in Hangzhou and the first stock of traditional Chinese medicine preparations in China. The company focuses on the traditional Chinese medicine industry and currently has four major business segments: pharmaceutical manufacturing, drug distribution, traditional Chinese medicine diagnosis and treatment, and health. The company is mainly engaged in the medical and health industry, engaged in R&D, manufacturing of pharmaceuticals and health foods and cultivation of Chinese herbal medicines. It is a pharmaceutical enterprise integrating R&D, manufacturing and sales of pharmaceuticals. The main products are Pearl Eye Drops, Amoxicillin and Clavulanate Potassium Tablets, Compound Bamboo Extract, River Che Daizao Capsule, Liuwei Dihuang Oral Liquid, Menthol, and Menthol Oil. Corporate honors: Huangshan Tianmu Pharmaceutical has won the National High-tech Enterprise Certificate, Zhejiang Standard Innovation Contribution Award Certificate, a tax credit unit, a leading municipal agricultural enterprise, and the “Gold Medal Time-honored Brand” honor issued by the Zhejiang Time-honored Brand Enterprise Association.
No Data